
In a major weight loss breakthrough published on November 20, 2026, researchers at the University of California, Berkeley have identified an experimental compound named TOFA that helps the body burn fat by increasing energy expenditure rather than suppressing appetite. Unlike popular GLP-1 medications such as Ozempic and Wegovy—which can lead to inadequate nutrition and unwanted muscle loss—this compound boosted energy expenditure by up to 18% in preclinical studies while preserving lean muscle mass. Scientists found that TOFA also improved blood sugar control and reduced liver fat, offering a promising new strategy to burn fat without muscle loss and even enhance existing obesity treatments.